STOCK TITAN

BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its upcoming participation at the TD Cowen 45th Annual Healthcare Conference in Boston, MA. The company's management will deliver a presentation on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM ET.

The presentation will be accessible through a live audio webcast via the company's investor relations website at investors.biomarin.com. For those unable to attend live, an archived version of the presentation will be made available on BioMarin's website for a time after the conference.

BioMarin Pharmaceutical (NASDAQ: BMRN) ha annunciato la sua prossima partecipazione alla 45ª Conferenza Annuale sulla Salute TD Cowen a Boston, MA. La direzione dell'azienda presenterà un intervento martedì 4 marzo 2025, alle 6:50 AM PT / 9:50 AM ET.

La presentazione sarà accessibile tramite una diretta audio sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.biomarin.com. Per coloro che non possono partecipare in diretta, una versione archiviata della presentazione sarà resa disponibile sul sito di BioMarin per un periodo di tempo dopo la conferenza.

BioMarin Pharmaceutical (NASDAQ: BMRN) ha anunciado su próxima participación en la 45ª Conferencia Anual de Salud TD Cowen en Boston, MA. La dirección de la empresa realizará una presentación el martes 4 de marzo de 2025, a las 6:50 AM PT / 9:50 AM ET.

La presentación estará disponible a través de una transmisión de audio en vivo en el sitio web de relaciones con inversores de la empresa en investors.biomarin.com. Para aquellos que no puedan asistir en vivo, se pondrá a disposición una versión archivada de la presentación en el sitio web de BioMarin por un tiempo después de la conferencia.

BioMarin Pharmaceutical (NASDAQ: BMRN)은 매사추세츠주 보스턴에서 열리는 TD Cowen 제45회 연례 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사 경영진은 2025년 3월 4일 화요일 오전 6:50 PT / 오전 9:50 ET에 발표를 진행할 것입니다.

발표는 회사의 투자자 관계 웹사이트인 investors.biomarin.com을 통해 라이브 오디오 웹캐스트로 접근할 수 있습니다. 실시간으로 참석할 수 없는 분들을 위해, 컨퍼런스 이후 일정 기간 동안 BioMarin 웹사이트에 발표의 아카이브 버전이 제공될 예정입니다.

BioMarin Pharmaceutical (NASDAQ: BMRN) a annoncé sa prochaine participation à la 45e Conférence Annuelle sur la Santé de TD Cowen à Boston, MA. La direction de l'entreprise fera une présentation le mardi 4 mars 2025, à 6h50 PT / 9h50 ET.

La présentation sera accessible via un webinaire audio en direct sur le site web des relations avec les investisseurs de l'entreprise à l'adresse investors.biomarin.com. Pour ceux qui ne peuvent pas assister en direct, une version archivée de la présentation sera mise à disposition sur le site de BioMarin pendant un certain temps après la conférence.

BioMarin Pharmaceutical (NASDAQ: BMRN) hat seine bevorstehende Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston, MA, bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 4. März 2025, um 6:50 Uhr PT / 9:50 Uhr ET eine Präsentation halten.

Die Präsentation wird über einen Live-Audio-Webcast auf der Investor-Relations-Website des Unternehmens unter investors.biomarin.com zugänglich sein. Für diejenigen, die nicht live teilnehmen können, wird eine archivierte Version der Präsentation für eine gewisse Zeit nach der Konferenz auf der Website von BioMarin zur Verfügung stehen.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Feb. 25, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM ET in Boston, MA.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com

Contacts:


Investors

Media

Traci McCarty

Marni Kottle

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558 

(650) 374-2803

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-tuesday-march-4-at-650-am-pt--950-am-et-in-boston-ma-302383918.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin (BMRN) presenting at the TD Cowen Healthcare Conference 2025?

BioMarin will present on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM ET in Boston, MA.

How can investors access BioMarin's (BMRN) TD Cowen conference presentation?

Investors can access the live audio webcast through BioMarin's investor relations website at investors.biomarin.com.

Will BioMarin's (BMRN) TD Cowen conference presentation be available after the event?

Yes, an archived version of the presentation will be available on BioMarin's website for a time following the conference.

Where is the TD Cowen Healthcare Conference featuring BioMarin (BMRN) being held?

The conference is being held in Boston, Massachusetts.

Biomarin Pharmaceutical Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

13.58B
188.91M
0.92%
97.72%
2.3%
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO